Clinical Trials Logo

Clinical Trial Summary

An increase of healthcare-associated infections caused by multidrug- resistant organisms (MRDO) is currently observed. One of the main causes of the emergence of a MDRO infection is an overuse of antibiotics. Therefore, saving useless antibiotic treatment is currently a priority from a public health point of view. The evaluation of the risk of having a bloodstream infection will allow both activating faster treatment decisions (when the risk is significantly high) or to save useless resources in terms of diagnostic tests and treatments, also limiting the potential for side effects (when the risk is significantly low).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05876598
Study type Observational
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact rita murri
Phone 003930154945
Email rita.murri@policlinicogemelli.it
Status Recruiting
Phase
Start date November 3, 2021
Completion date December 30, 2025